{
    "startDate": "2020-04-01",
    "endDate": "2020-06-30",
    "year": "2020",
    "quarter": "Q1",
    "symbol": "UROV",
    "data": {
        "bs": [
            {
                "label": "Cash and restricted cash\u2014beginning of period",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": 63912000
            },
            {
                "label": "Cash and restricted cash\u2014beginning of period",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": 63912000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -30494000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 77000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 2038000
            },
            {
                "label": "Amortization of debt discount and issuance costs",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 18000
            },
            {
                "label": "Non-cash operating lease cost.",
                "concept": "urov:NoncashOperatingLeaseCost",
                "unit": "usd",
                "value": 229000
            },
            {
                "label": "Unrealized foreign currency translation adjustment",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": -43000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 2491000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherCurrentAssets",
                "unit": "usd",
                "value": 60000
            },
            {
                "label": "Due from Sumitovant Biopharma Ltd.",
                "concept": "IncreaseDecreaseInDueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": -172000
            },
            {
                "label": "Increase (decrease) in due to related party current.",
                "concept": "urov:IncreaseDecreaseInDueToRelatedPartyCurrent",
                "unit": "usd",
                "value": -29000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -1459000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 1342000
            },
            {
                "label": "Increase (decrease) in operating lease liabilities.",
                "concept": "urov:IncreaseDecreaseInOperatingLeaseLiabilities",
                "unit": "usd",
                "value": -186000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -30800000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquireFurnitureAndFixtures",
                "unit": "usd",
                "value": 104000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -104000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 1205000
            },
            {
                "label": "Cash proceeds from related-party debt financing",
                "concept": "ProceedsFromRelatedPartyDebt",
                "unit": "usd",
                "value": 41000000
            },
            {
                "label": "Proceeds from issuance of common shares pursuant to 2019 ESPP",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 331000
            },
            {
                "label": "Net cash provided by (used in) financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 42536000
            },
            {
                "label": "Net change in cash and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 11632000
            },
            {
                "label": "Reclassification of share-based compensation liabilities to additional paid-in capital upon exercise of stock options.",
                "concept": "urov:ReclassificationOfShareBasedCompensationLiabilitiesToAdditionalPaidInCapitalUponExerciseOfStockOptions",
                "unit": "usd",
                "value": 988000
            },
            {
                "label": "Reclassification of share-based compensation expense from additional paid-in capital to liabilities",
                "concept": "urov:ReclassificationOfShareBasedCompensationExpenseFromAdditionalPaidInCapitalToLiabilities",
                "unit": "usd",
                "value": 35000
            },
            {
                "label": "Interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 1438000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 16354000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 12489000
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 28843000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNet",
                "unit": "usd",
                "value": -1443000
            },
            {
                "label": "Other expense, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -118000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -30404000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 90000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -30494000
            },
            {
                "label": "Net loss per common share\u2014basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.99
            },
            {
                "label": "Weighted average common shares outstanding\u2014basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 30705334
            }
        ]
    }
}